EPIC Program Annual Data Tables 2004-2005: Table IX

Table IX
Top Twenty Drugs Based on EPIC Payments
Rank by
Payment
DrugStrengthDrug
Type**
Number
of Claims
EPIC PaymentsRank by Number
of Claims
Top 20 Totals1,697,127$230,881,534
Percent of Top 20 Drugs to Total EPIC Payments15.3%30.9%
1PLAVIX75MGSS163,485$28,794,6963
2NEXIUM40MGSS85,113$17,767,78016
3PREVACID30MGSS89,151$17,574,09414
4LIPITOR10MGSS170,901$16,637,4022
5LIPITOR20MGSS110,462$16,473,35710
6PROTONIX40MGSS112,131$15,990,2888
7FOSAMAX70MGSS159,708$15,459,3484
8ZOCOR20MGSS65,788$13,107,77623
9ZOCOR40MGSS45,987$9,038,01043
10PRAVACHOL40MGSS40,349$8,471,55751
11NORVASC5MGSS134,163$8,030,7655
12ARICEPT10MGSS46,328$7,927,50442
13NORVASC10MGSS97,926$7,846,01413
14LIPITOR40MGSS49,719$7,625,06737
15ACTONEL35MGSS79,042$7,029,02718
16CELEBREX200MGSS53,892$6,999,44129
17ACIPHEX20MGSS35,058$6,832,27462
18ZETIA10MGSS61,042$6,637,21126
19OMEPRAZOLE20MGGen43,657$6,404,13445
20ADVAIR DISKUS250-50 MCGSS53,225$6,235,78933

*Table IX lists the top 20 drugs ranked by EPIC Payments and number of adjudicated claims for the program year (October 1, 2004-September 30, 2005) as well as the percentage of the totals they represent for the year.

** Drug Type values are Gen='Generic' and SS='Sole Source'.